The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.
The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network ...
More than three-quarters of American adults didn't get a COVID shot last season, a figure that health care experts warn could ...
Grim revelations have surfaced from within the Department of Health and Human Services (HHS), exposing a culture of censorship surrounding critical discussions about the COVID-19 vaccine and its ...
Delaware says COVID-19 vaccines are available at state clinics, regardless of insurance status. But only 2 clinics carried ...
The oropharyngeal cancer market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as PDS Biotechnology's Versamune HPV, Inovio ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
The company posted a net loss of 51 cents a share, against Wall Street’s expectation for a loss of $2.21. Moderna has ...
Moderna surged on reports of talks with a large biopharma for a potential partnership or buyout, despite trading at multi-year lows. MRNA's promising cancer vaccine data and surprising findings on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback